NEO – Neogenomics Inc.
NeoGenomics, Inc.NEO
$11.44Name : NeoGenomics, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $1,489,622,656.00
EPSttm : -0.77
NeoGenomics, Inc.
$11.44
4.47%$0.49
NEO — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.75
Margin Of Safety %
Put/Call OI Ratio
0.07
EPS Next Q Diff
-0.08
EPS Last/This Y
1.02
EPS This/Next Y
0.18
Price
11.44
Target Price
15.06
Analyst Recom
1.67
Performance Q
33.64
Upside
-335.6%
Beta
1.78
Ticker: NEO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | NEO | 8.65 | 0.16 | 0.11 | 11070 |
| 2026-05-12 | NEO | 8.76 | 0.16 | 0.00 | 11069 |
| 2026-05-13 | NEO | 8.27 | 0.16 | 0.12 | 11037 |
| 2026-05-14 | NEO | 8.36 | 0.16 | 0.00 | 11073 |
| 2026-05-15 | NEO | 8.23 | 0.15 | 0.03 | 11082 |
| 2026-05-18 | NEO | 8.36 | 0.11 | 0.00 | 5984 |
| 2026-05-19 | NEO | 8.39 | 0.11 | 0.04 | 5991 |
| 2026-05-20 | NEO | 8.9 | 0.11 | 0.00 | 6102 |
| 2026-05-21 | NEO | 9.11 | 0.11 | 0.00 | 6412 |
| 2026-05-22 | NEO | 9.22 | 0.10 | 0.01 | 6509 |
| 2026-05-26 | NEO | 9.27 | 0.10 | 0.00 | 6662 |
| 2026-05-27 | NEO | 9.57 | 0.10 | 0.00 | 6681 |
| 2026-05-28 | NEO | 10.21 | 0.10 | 0.00 | 6900 |
| 2026-05-29 | NEO | 10.52 | 0.09 | 0.02 | 7294 |
| 2026-06-02 | NEO | 10.12 | 0.09 | 0.18 | 7658 |
| 2026-06-03 | NEO | 10.15 | 0.09 | 0.01 | 7664 |
| 2026-06-04 | NEO | 11.3 | 0.08 | 0.21 | 8041 |
| 2026-06-05 | NEO | 10.9 | 0.07 | 0.04 | 9991 |
| 2026-06-08 | NEO | 10.95 | 0.07 | 0.05 | 10100 |
| 2026-06-09 | NEO | 11.44 | 0.07 | 0.02 | 10154 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | NEO | 8.65 | 12.1 | - | 0.18 |
| 2026-05-12 | NEO | 8.76 | 12.1 | - | 0.18 |
| 2026-05-13 | NEO | 8.26 | 12.1 | - | 0.18 |
| 2026-05-14 | NEO | 8.35 | 12.1 | - | 0.18 |
| 2026-05-15 | NEO | 8.24 | 12.1 | - | 0.18 |
| 2026-05-18 | NEO | 8.36 | 12.1 | - | 0.18 |
| 2026-05-19 | NEO | 8.38 | 12.1 | - | 0.18 |
| 2026-05-20 | NEO | 8.89 | 12.1 | - | 0.18 |
| 2026-05-21 | NEO | 9.11 | 12.1 | - | 0.18 |
| 2026-05-22 | NEO | 9.23 | 12.1 | - | 0.18 |
| 2026-05-26 | NEO | 9.26 | 12.1 | - | 0.18 |
| 2026-05-27 | NEO | 9.58 | 12.1 | - | 0.18 |
| 2026-05-28 | NEO | 10.20 | 12.1 | - | 0.18 |
| 2026-05-29 | NEO | 10.52 | 12.1 | - | 0.18 |
| 2026-06-01 | NEO | 10.44 | 12.1 | - | 0.18 |
| 2026-06-02 | NEO | 10.12 | 12.1 | - | 0.18 |
| 2026-06-03 | NEO | 10.15 | 12.1 | - | 0.18 |
| 2026-06-04 | NEO | 11.31 | 12.1 | - | 0.18 |
| 2026-06-05 | NEO | 10.90 | 12.1 | - | 0.18 |
| 2026-06-08 | NEO | 10.94 | 12.1 | - | 0.18 |
| 2026-06-09 | NEO | 11.44 | 12.1 | - | 0.18 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | NEO | -1.84 | 10.47 | 6.16 |
| 2026-05-12 | NEO | -1.84 | 10.47 | 7.46 |
| 2026-05-13 | NEO | -1.86 | 10.47 | 7.46 |
| 2026-05-14 | NEO | -1.86 | 10.47 | 7.46 |
| 2026-05-15 | NEO | -1.86 | 10.47 | 7.46 |
| 2026-05-18 | NEO | -1.86 | 14.38 | 7.46 |
| 2026-05-19 | NEO | -1.87 | 14.38 | 7.46 |
| 2026-05-20 | NEO | -1.87 | 14.38 | 7.46 |
| 2026-05-21 | NEO | -1.87 | 14.38 | 7.46 |
| 2026-05-22 | NEO | -1.87 | 14.38 | 7.46 |
| 2026-05-26 | NEO | -1.87 | 5.89 | 7.46 |
| 2026-05-27 | NEO | -1.87 | 5.89 | 7.46 |
| 2026-05-28 | NEO | -1.87 | 5.89 | 6.74 |
| 2026-05-29 | NEO | -0.97 | 5.89 | 6.74 |
| 2026-06-02 | NEO | -0.97 | 5.48 | 6.74 |
| 2026-06-03 | NEO | -0.97 | 5.48 | 6.74 |
| 2026-06-04 | NEO | -0.97 | 5.48 | 6.74 |
| 2026-06-05 | NEO | -0.97 | 5.48 | 6.74 |
| 2026-06-08 | NEO | -0.97 | 5.44 | 6.75 |
| 2026-06-09 | NEO | -0.90 | 5.44 | 6.75 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.13
Avg. EPS Est. Current Quarter
0.03
Avg. EPS Est. Next Quarter
0.05
Insider Transactions
-0.9
Institutional Transactions
5.44
Beta
1.78
Average Sales Estimate Current Quarter
196
Average Sales Estimate Next Quarter
205
Fair Value
Quality Score
43
Growth Score
43
Sentiment Score
82
Actual DrawDown %
79.1
Max Drawdown 5-Year %
-90.8
Target Price
15.06
P/E
Forward P/E
31.38
PEG
0.51
P/S
2
P/B
1.79
P/Free Cash Flow
EPS
-0.77
Average EPS Est. Cur. Y
0.18
EPS Next Y. (Est.)
0.36
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-13.3
Relative Volume
1.06
Return on Equity vs Sector %
-39.5
Return on Equity vs Industry %
-22.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
◆
NEO
Healthcare
$11.44
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
72.2
Range 1M
94.9%
Sup Dist
5.4%
Momentum Growth
Ride accelerating trends
WATCH
EPS Yr
50%
EPS NY
102.5%
52W%
74.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+16.2% upside
Upside
+16.2%
Quality
43
NeoGenomics, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2500
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
NEO
Latest News
—
Caricamento notizie per NEO…
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading